Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Patrice, Gibbons"'
Autor:
Thomas Sudhop, Michael Reber, Diane Tribble, Aditi Sapre, William Taggart, Patrice Gibbons, Thomas Musliner, Klaus von Bergmann, Dieter Lütjohann
Publikováno v:
Journal of Lipid Research, Vol 50, Iss 10, Pp 2117-2123 (2009)
This study evaluates changes in cholesterol balance in hypercholesterolemic subjects following treatment with an inhibitor of cholesterol absorption or cholesterol synthesis or coadministration of both agents. This was a randomized, double blind, pla
Externí odkaz:
https://doaj.org/article/245ccf5a96b741e9840048470f179342
Autor:
Christopher P, Cannon, Sukrut, Shah, Hayes M, Dansky, Michael, Davidson, Eliot A, Brinton, Antonio M, Gotto, Michael, Stepanavage, Sherry Xueyu, Liu, Patrice, Gibbons, Tanya B, Ashraf, Jennifer, Zafarino, Yale, Mitchel, Philip, Barter, T O, Wahl
Publikováno v:
The New England journal of medicine
Background Anacetrapib is a cholesteryl ester transfer protein inhibitor that raises high-density lipoprotein (HDL) cholesterol and reduces low-density lipoprotein (LDL) cholesterol. Methods We conducted a randomized, double-blind, placebo-controlled
Autor:
Christopher P, Cannon, Hayes M, Dansky, Michael, Davidson, Antonio M, Gotto, Eliot A, Brinton, A Lawrence, Gould, Michael, Stepanavage, Sherry Xueyu, Liu, Sukrut, Shah, Joseph, Rubino, Patrice, Gibbons, Anne, Hermanowski-Vosatka, Bruce, Binkowitz, Yale, Mitchel, Philip, Barter, Andrew, Tonkin
Publikováno v:
American heart journal, 158(4), 513-519.e3. Mosby Inc.
American heart journal
American heart journal
Background Residual cardiovascular (CV) risk often remains high despite statin therapy to lower low-density lipoprotein cholesterol (LDL-C). New therapies to raise high-density lipoprotein cholesterol (HDL-C) are currently being investigated. Anacetr